PHA-767491
98%
- Product Code: 101997
CAS:
845714-00-3
| Molecular Weight: | 213.24 g./mol | Molecular Formula: | C₁₂H₁₁N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
PHA-767491 is primarily used in research settings as a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) and cell division cycle 7 (CDC7). Its application is significant in studying cell cycle regulation, particularly in understanding the mechanisms of DNA replication and cell division. Researchers utilize this compound to explore its effects on cancer cells, as inhibiting CDC7 can potentially halt the proliferation of tumor cells. Additionally, PHA-767491 is employed in neurodegenerative disease studies, given its role in modulating DYRK1A, which is implicated in conditions like Alzheimer's disease. Its ability to cross the blood-brain barrier makes it a valuable tool in neuroscience research, aiding in the investigation of therapeutic strategies for brain-related disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | Ft73,210.06 |
+
-
|
| 0.050 | 10-20 days | Ft301,373.35 |
+
-
|
PHA-767491
PHA-767491 is primarily used in research settings as a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) and cell division cycle 7 (CDC7). Its application is significant in studying cell cycle regulation, particularly in understanding the mechanisms of DNA replication and cell division. Researchers utilize this compound to explore its effects on cancer cells, as inhibiting CDC7 can potentially halt the proliferation of tumor cells. Additionally, PHA-767491 is employed in neurodegenerative disease studies, given its role in modulating DYRK1A, which is implicated in conditions like Alzheimer's disease. Its ability to cross the blood-brain barrier makes it a valuable tool in neuroscience research, aiding in the investigation of therapeutic strategies for brain-related disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :